Momentum Is Strong For Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Centessa Pharmaceuticals plc ADR is $2.01B. A total of 0.85 million shares were traded on the day, compared to an average of 901.10K shares.

In the most recent transaction, HUSSAIN IQBAL J bought 6,000 shares of CNTA for 14.93 per share on Jul 15 ’25. In a previous transaction on Jun 25 ’25, Weinhoff Gregory M sold 10,000 shares at 13.86 per share. CNTA shares that Chief Business Officer owns now total 122,279.

Among the insiders who sold shares, HUSSAIN IQBAL J disposed of 12,000 shares on Jun 24 ’25 at a per-share price of $14.02. This resulted in the General Counsel holding 105,386 shares of CNTA after the transaction. In another insider transaction, Accardi Mario Alberto sold 15,000 shares at $14.00 per share on Jun 24 ’25. Company shares held by the President, Orexin Program now total 216,485.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CNTA has a high of $19.09 and a low of $9.00.

As of this writing, CNTA has an earnings estimate of -$0.34 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.37.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CNTA’s latest balance sheet shows that the firm has $595.08M in Cash & Short Term Investments as of fiscal 2021. There were $75.70M in debt and $24.64M in liabilities at the time. Its Book Value Per Share was $2.89, while its Total Shareholder’s Equity was $491.55M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CNTA is Buy with a score of 4.91.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.